Cargando…
Prevalence of hepatocarcinoma-related hepatitis B virus mutants in patients in grey zone of treatment
BACKGROUND: Antiviral treatment of patients with chronic hepatitis B (CHB) in the grey zone of treatment comands risk management in order to optimize the health outcome. In this sense, the identification of HBV mutants related with an increased risk of hepatocellular carcinoma (HCC) could be useful...
Autores principales: | Gil-García, Ana Isabel, Madejón, Antonio, Francisco-Recuero, Irene, López-López, Ana, Villafranca, Emiliana, Romero, Miriam, García, Araceli, Olveira, Antonio, Mena, Rocío, Larrubia, Juan Ramón, García-Samaniego, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Baishideng Publishing Group Inc
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6801187/ https://www.ncbi.nlm.nih.gov/pubmed/31636479 http://dx.doi.org/10.3748/wjg.v25.i38.5883 |
Ejemplares similares
-
Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells
por: García-Crespo, Carlos, et al.
Publicado: (2023) -
Some light in the grey zone?
por: Bickenbach, J., et al.
Publicado: (2017) -
Nosocomial Transmission of SARS-CoV-2 Involving Vaccinated Health Care Workers
por: Pérez-Lago, Laura, et al.
Publicado: (2022) -
A Mycobacterium tuberculosis Cytochrome bd Oxidase Mutant Is Hypersensitive to Bedaquiline
por: Berney, Michael, et al.
Publicado: (2014) -
Sterilization by Adaptive Immunity of a Conditionally Persistent Mutant of Mycobacterium tuberculosis
por: Vilchèze, Catherine, et al.
Publicado: (2021)